Literature DB >> 32309293

Hypomagnesemia and Short-Term Mortality in Elderly Maintenance Hemodialysis Patients.

Caibao Lu1, Yiqin Wang1, Daihong Wang1, Ling Nie1, Ying Zhang1, Qiuyu Lei1, Jiachuan Xiong1, Jinghong Zhao1.   

Abstract

BACKGROUND: The relationship between magnesium and mortality in hemodialysis patients has been evaluated in several prospective studies, but few have assessed the risk of all-cause mortality in elderly hemodialysis patients. The aim of this study was to evaluate the association between magnesium levels and the risk of cardiovascular and overall mortality in elderly maintenance hemodialysis patients.
METHODS: This was a retrospective study, and patients undergoing maintenance hemodialysis were screened for eligibility at a single dialysis center between July and December 2016. Patients were divided into two groups based on their magnesium levels: a low magnesium level group and a high magnesium level group. Associations between magnesium level and risk of cardiovascular and all-cause mortality were analyzed with a Cox proportional hazards regression model.
RESULTS: In total, 413 patients were included with a median follow-up period of 12 months. We found that compared to patients with high magnesium levels, those with low magnesium levels had significantly lower levels of hemoglobin, urea, creatinine, uric acid, phosphate, potassium, chloride, albumin, and spKt/V (p < 0.05 for each parameter). There was a strong correlation between the baseline mean serum magnesium concentration 1 year prior and the concentration 1 year later (r<sup>2</sup> = 0.519, p < 0.001). After adjustment for confounding factors, multivariate Cox proportional hazards analysis showed hypomagnesemia to be an independent predictor of all-cause and cardiovascular mortality in chronic hemodialysis patients. Furthermore, subgroup analysis was performed, revealing that serum magnesium levels were still strongly associated with all-cause mortality and cardiovascular mortality in patients older than 60 years, with HR values of 0.020 (95% CI 0.001-0.415) and 0.010 (95% CI 0.000-0.491), respectively. In addition, there were still significant associations between the serum magnesium level and all-cause mortality and cardiovascular mortality in elderly dialysis patients at the 6-month follow-up visit.
CONCLUSION: Our study indicates that lower serum magnesium levels are strongly associated with cardiovascular and all-cause mortality in maintenance hemodialysis patients, especially in the short term and in those who are elderly. Factors affecting serum magnesium concentrations in hemodialysis patients should be investigated, and correcting hypomagnesemia may benefit elderly hemodialysis patients.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Hemodialysis; Magnesium; Mortality; Risk factor

Year:  2019        PMID: 32309293      PMCID: PMC7154288          DOI: 10.1159/000504601

Source DB:  PubMed          Journal:  Kidney Dis (Basel)        ISSN: 2296-9357


  32 in total

Review 1.  Magnesium and cardiovascular system.

Authors:  Michael Shechter
Journal:  Magnes Res       Date:  2010-03-31       Impact factor: 1.115

Review 2.  Magnesium: physiology and pharmacology.

Authors:  W J Fawcett; E J Haxby; D A Male
Journal:  Br J Anaesth       Date:  1999-08       Impact factor: 9.166

3.  Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study.

Authors:  Rika Ago; Toshihiro Shindo; Masataka Banshodani; Sadanori Shintaku; Misaki Moriishi; Takao Masaki; Hideki Kawanishi
Journal:  Hemodial Int       Date:  2016-06-21       Impact factor: 1.812

4.  Hypomagnesemia and Mortality in Incident Hemodialysis Patients.

Authors:  Lin Li; Elani Streja; Connie M Rhee; Rajnish Mehrotra; Melissa Soohoo; Steven M Brunelli; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2015-07-14       Impact factor: 8.860

Review 5.  Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies.

Authors:  Jingjing Da; Xinfang Xie; Myles Wolf; Sinee Disthabanchong; Jinwei Wang; Yan Zha; Jicheng Lv; Luxia Zhang; Haiyan Wang
Journal:  Am J Kidney Dis       Date:  2015-03-21       Impact factor: 8.860

Review 6.  Magnesium in chronic kidney disease: challenges and opportunities.

Authors:  Mehmet Kanbay; David Goldsmith; Mehtap Erkmen Uyar; Faruk Turgut; Adrian Covic
Journal:  Blood Purif       Date:  2010-01-21       Impact factor: 2.614

7.  Serum magnesium level and vascular stiffness in children with chronic kidney disease on regular hemodialysis.

Authors:  Manal Mohamed Zaher; Manal Abdel-Salam; Ragaa Abdel-Salam; Randa Sabour; Amal Abd El-Aleem Morsy; Dina Gamal
Journal:  Saudi J Kidney Dis Transpl       Date:  2016-03

8.  Angiotensin II prevents calcification in vascular smooth muscle cells by enhancing magnesium influx.

Authors:  Carmen Herencia; M Encarnacion Rodríguez-Ortiz; Juan R Muñoz-Castañeda; Julio Manuel Martinez-Moreno; Rocío Canalejo; Addy Montes de Oca; Juan M Díaz-Tocados; Esther Peralbo-Santaella; Carmen Marín; Antonio Canalejo; Mariano Rodriguez; Yolanda Almaden
Journal:  Eur J Clin Invest       Date:  2015-09-13       Impact factor: 4.686

9.  Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival.

Authors:  Ziad A Massy; Tilman B Drüeke
Journal:  Clin Kidney J       Date:  2012-02

10.  Serum Magnesium and Sudden Death in European Hemodialysis Patients.

Authors:  Camiel L M de Roij van Zuijdewijn; Muriel P C Grooteman; Michiel L Bots; Peter J Blankestijn; Sonja Steppan; Janine Büchel; Rolf H H Groenwold; Vincent Brandenburg; Marinus A van den Dorpel; Piet M Ter Wee; Menso J Nubé; Marc G Vervloet
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

View more
  4 in total

1.  Clinical Factors Associated with Serum Magnesium Concentration in Patients Undergoing Peritoneal Dialysis: A Single-Center Observational Study.

Authors:  Shohei Kaneko; Susumu Ookawara; Yoshiyuki Morishita
Journal:  Int J Nephrol Renovasc Dis       Date:  2022-05-24

2.  Associations between the serum magnesium and all-cause or cardiovascular mortality in chronic kidney disease and end-stage renal disease patients: A meta-analysis.

Authors:  Hongyan Liu; Rui Wang
Journal:  Medicine (Baltimore)       Date:  2021-11-12       Impact factor: 1.817

3.  Association between hypomagnesemia and mortality among dialysis patients: a systematic review and meta-analysis.

Authors:  Chi-Ya Huang; Chi-Chen Yang; Kuo-Chuan Hung; Ming-Yan Jiang; Yun-Ting Huang; Jyh-Chang Hwang; Chih-Chieh Hsieh; Min-Hsiang Chuang; Jui-Yi Chen
Journal:  PeerJ       Date:  2022-10-11       Impact factor: 3.061

4.  Prognostic Value of Serum Magnesium in Mortality Risk among Patients on Hemodialysis: A Meta-Analysis of Observational Studies.

Authors:  Hongwei Wu; Qiang Li; Lijing Fan; Dewang Zeng; Xianggeng Chi; Baozhang Guan; Bo Hu; Yongping Lu; Chen Yun; Bernhard Krämer; Berthold Hocher; Fanna Liu; Lianghong Yin
Journal:  Kidney Dis (Basel)       Date:  2020-11-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.